138 related articles for article (PubMed ID: 24344948)
1. Sudden hearing loss associated with tacrolimus after pediatric renal transplant.
Gulleroglu K; Baskin E; Bayrakci U; Aydin E; Ozluoglu L; Moray G; Haberal M
Exp Clin Transplant; 2013 Dec; 11(6):562-4. PubMed ID: 24344948
[TBL] [Abstract][Full Text] [Related]
2. Sudden hearing loss associated with tacrolimus in a kidney-pancreas allograft recipient.
Min DI; Ku YM; Rayhill S; Corwin C; Wu YM; Hunsicker LG
Pharmacotherapy; 1999 Jul; 19(7):891-3. PubMed ID: 10417040
[TBL] [Abstract][Full Text] [Related]
3. Hearing Status in Pediatric Renal Transplant Recipients.
Gulleroglu K; Baskin E; Aydin E; Ozluoglu L; Moray G; Haberal M
Exp Clin Transplant; 2015 Aug; 13(4):324-8. PubMed ID: 25365361
[TBL] [Abstract][Full Text] [Related]
4. Sudden hearing loss associated with tacrolimus in a liver transplant recipient.
Norman K; Bonatti H; Dickson RC; Aranda-Michel J
Transpl Int; 2006 Jul; 19(7):601-3. PubMed ID: 16764642
[No Abstract] [Full Text] [Related]
5. Audiological follow-up in transplant patients treated with calcineurin immunosuppressants "Calcineurin inhibitors and Ototoxicity".
Heider C; Waissbluth S; Oyarzún J; Calderara G; Leung JS; Novoa I
Rev Med Chil; 2023 Jun; 151(6):702-710. PubMed ID: 38801378
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
7. Severe hearing loss after liver transplantation.
Rifai K; Bahr MJ; Cantz T; Klempnauer J; Manns MP; Strassburg CP
Transplant Proc; 2005 May; 37(4):1918-9. PubMed ID: 15919504
[TBL] [Abstract][Full Text] [Related]
8. Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients.
Furth S; Neu A; Colombani P; Plotnick L; Turner ME; Fivush B
Pediatr Nephrol; 1996 Feb; 10(1):64-6. PubMed ID: 8611359
[TBL] [Abstract][Full Text] [Related]
9. Hearing Impairments as an Overlooked Condition in Kidney Transplant Recipients.
Simsir M; Yildiz MG; Karatas M; Dalgic A; Ozturk I; Tatar E; Eren N; Erken E; Gungor O; Altunoren O
Transpl Int; 2022; 35():10198. PubMed ID: 35497888
[TBL] [Abstract][Full Text] [Related]
10. Anorexia nervosa in a pediatric renal transplant recipient and its reversal with cyclosporine.
Okechuku G; Boulos AK; Herman L; Upadhyay K
Pediatr Transplant; 2015 May; 19(3):E78-82. PubMed ID: 25661468
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.
Ellis D; Jaffe R; Green M; Janosky JJ; Lombardozzi-Lane S; Shapiro R; Scantlebury V; Vivas C; Jordan ML
Transplantation; 1999 Oct; 68(7):997-1003. PubMed ID: 10532541
[TBL] [Abstract][Full Text] [Related]
12. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitors in renal transplantation: what is the best option?
Tanabe K
Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
[TBL] [Abstract][Full Text] [Related]
14. Sensorineural Deafness Following Tacrolimus Use.
Lakshmi BS; Vidya B; Reddy MHK; Kumar ACV; Ram R; Kumar VS
Exp Clin Transplant; 2020 Feb; 18(1):110-111. PubMed ID: 29969081
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.
Lancia P; Adam de Beaumais T; Elie V; Garaix F; Fila M; Nobili F; Ranchin B; Testevuide P; Ulinski T; Zhao W; Deschênes G; Jacqz-Aigrain E
Pediatr Nephrol; 2018 Jun; 33(6):1045-1055. PubMed ID: 29399716
[TBL] [Abstract][Full Text] [Related]
16. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus: the good, the bad, and the ugly.
Chand DH; Southerland SM; Cunningham RJ
Pediatr Transplant; 2001 Feb; 5(1):32-6. PubMed ID: 11260486
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients.
Hakeam HA; Al-Jedai AH; Raza SM; Hamawi K
Ann Transplant; 2008; 13(2):46-53. PubMed ID: 18566560
[TBL] [Abstract][Full Text] [Related]
19. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin inhibitors in pediatric renal transplant recipients.
Filler G
Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
